{"id":"azithromycin","rwe":[],"tags":[],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DRUG HYPERSENSITIVITY","source":"FDA FAERS","actionTaken":"Reported 1979 times"},{"date":"","signal":"DYSPNOEA","source":"FDA FAERS","actionTaken":"Reported 1312 times"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"Reported 1036 times"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"Reported 1030 times"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"Reported 989 times"},{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"Reported 971 times"},{"date":"","signal":"PNEUMONIA","source":"FDA FAERS","actionTaken":"Reported 924 times"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"Reported 881 times"},{"date":"","signal":"COUGH","source":"FDA FAERS","actionTaken":"Reported 866 times"},{"date":"","signal":"VOMITING","source":"FDA FAERS","actionTaken":"Reported 824 times"}],"drugInteractions":[{"drug":"Nelfinavir","action":"Monitor","effect":"liver enzyme abnormalities and hearing impairment"},{"drug":"Warfarin","action":"Monitor","effect":"coagulation times"},{"drug":"Digoxin","action":"Monitor","effect":"unknown"},{"drug":"Colchicine","action":"Monitor","effect":"unknown"},{"drug":"Phenytoin","action":"Monitor","effect":"unknown"}],"commonSideEffects":[{"effect":"Nausea","drugRate":"4%","severity":"mild"},{"effect":"Diarrhea","drugRate":"4%","severity":"mild"},{"effect":"Abdominal pain","drugRate":"3%","severity":"mild"},{"effect":"Vomiting","drugRate":"1%","severity":"mild"},{"effect":"Pain at the injection site","drugRate":"6.5%","severity":"mild"},{"effect":"Local inflammation","drugRate":"3.1%","severity":"mild"},{"effect":"Diarrhea","drugRate":"8.5%","severity":"mild"},{"effect":"Nausea","drugRate":"6.6%","severity":"mild"},{"effect":"Vaginitis","drugRate":"2.8%","severity":"mild"},{"effect":"Abdominal pain","drugRate":"1.9%","severity":"mild"},{"effect":"Anorexia","drugRate":"1.9%","severity":"mild"},{"effect":"Rash and pruritus","drugRate":"1.9%","severity":"mild"},{"effect":"Dyspepsia","drugRate":"1%","severity":"mild"},{"effect":"Flatulence","drugRate":"1%","severity":"mild"},{"effect":"Mucositis","drugRate":"1%","severity":"mild"},{"effect":"Oral moniliasis","drugRate":"1%","severity":"mild"},{"effect":"Gastritis","drugRate":"1%","severity":"mild"},{"effect":"Headache","drugRate":"1%","severity":"mild"},{"effect":"Somnolence","drugRate":"1%","severity":"mild"},{"effect":"Bronchospasm","drugRate":"1%","severity":"mild"},{"effect":"Taste perversion","drugRate":"1%","severity":"mild"},{"effect":"Anorexia","drugRate":"1%","severity":"mild"},{"effect":"Constipation","drugRate":"1%","severity":"mild"},{"effect":"Dyspepsia","drugRate":"1%","severity":"mild"},{"effect":"Flatulence","drugRate":"1%","severity":"mild"},{"effect":"Vomiting/diarrhea","drugRate":"1%","severity":"mild"},{"effect":"Pseudomembranous colitis","drugRate":"1%","severity":"mild"},{"effect":"Pancreatitis","drugRate":"1%","severity":"serious"},{"effect":"Oral candidiasis","drugRate":"1%","severity":"mild"},{"effect":"Pyloric stenosis","drugRate":"1%","severity":"serious"},{"effect":"Tongue discoloration","drugRate":"1%","severity":"mild"},{"effect":"Asthenia","drugRate":"1%","severity":"mild"},{"effect":"Paresthesia","drugRate":"1%","severity":"mild"},{"effect":"Fatigue","drugRate":"1%","severity":"mild"},{"effect":"Malaise","drugRate":"1%","severity":"mild"},{"effect":"Anaphylaxis","drugRate":"1%","severity":"serious"},{"effect":"Interstitial nephritis","drugRate":"1%","severity":"serious"},{"effect":"Acute renal failure","drugRate":"1%","severity":"serious"},{"effect":"Vaginitis","drugRate":"1%","severity":"mild"},{"effect":"Thrombocytopenia","drugRate":"1%","severity":"serious"},{"effect":"Abnormal liver function","drugRate":"1%","severity":"serious"},{"effect":"Hepatitis","drugRate":"1%","severity":"serious"},{"effect":"Cholestatic jaundice","drugRate":"1%","severity":"serious"},{"effect":"Hepatic necrosis","drugRate":"1%","severity":"serious"},{"effect":"Hepatic failure","drugRate":"1%","severity":"serious"},{"effect":"Convulsions","drugRate":"1%","severity":"serious"},{"effect":"Dizziness/vertigo","drugRate":"1%","severity":"mild"},{"effect":"Headache","drugRate":"1%","severity":"mild"},{"effect":"Somnolence","drugRate":"1%","severity":"mild"},{"effect":"Hyperactivity","drugRate":"1%","severity":"mild"},{"effect":"Nervousness","drugRate":"1%","severity":"mild"},{"effect":"Agitation","drugRate":"1%","severity":"mild"},{"effect":"Syncope","drugRate":"1%","severity":"mild"},{"effect":"Aggressive reaction","drugRate":"1%","severity":"serious"},{"effect":"Anxiety","drugRate":"1%","severity":"mild"},{"effect":"Pruritus","drugRate":"1%","severity":"mild"},{"effect":"Erythema multiforme","drugRate":"1%","severity":"serious"},{"effect":"AGEP","drugRate":"1%","severity":"serious"},{"effect":"Stevens-Johnson syndrome","drugRate":"1%","severity":"serious"},{"effect":"Toxic epidermal necrolysis","drugRate":"1%","severity":"serious"},{"effect":"DRESS","drugRate":"1%","severity":"serious"},{"effect":"Hearing disturbances","drugRate":"1%","severity":"serious"},{"effect":"Hearing loss","drugRate":"1%","severity":"serious"},{"effect":"Deafness","drugRate":"1%","severity":"serious"},{"effect":"Tinnitus","drugRate":"1%","severity":"mild"},{"effect":"Taste/smell perversion and/or loss","drugRate":"1%","severity":"mild"}],"contraindications":["Chronic heart failure","Congenital long QT syndrome","Disease of liver","Hearing disorder","Jaundice","Liver function tests abnormal","Myasthenia gravis","Prolonged QT interval","Pseudomembranous enterocolitis","Torsades de pointes"],"specialPopulations":{"Pregnancy":"Available data from published literature and postmarketing experience over several decades with azithromycin use in pregnant women have not identified any drug-associated risks for major birth defects, miscarriage, or adverse maternal or fetal outcomes. Developmental toxicity studies with azithromycin in rats, mice, and rabbits showed no drug-induced fetal malformations at doses up to 4, 2, and 2 times, respectively, an adult human daily dose of 500 mg based on body surface area.","Geriatric use":"Elderly patients may be more susceptible to development of torsades de pointes arrhythmias. Pharmacokinetics of azithromycin following oral administration in older volunteers (65–85 years old) were similar to those in younger volunteers (18–40 years old) for the 5-day therapeutic regimen.","Paediatric use":"Safety and effectiveness in the treatment of patients under 16 years of age have not been established.","Renal impairment":"No information available","Hepatic impairment":"No information available"},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"approved","trials":["NCT00002082","NCT04353180","NCT04319705","NCT01269658","NCT00741052","NCT04047849","NCT02544984","NCT03801252","NCT04405310","NCT04424511","NCT04062175","NCT04329572","NCT04344444","NCT02344628","NCT00000883","NCT01102244","NCT00538148","NCT01109160","NCT03220074","NCT05677282","NCT04381936","NCT00354952","NCT06349122","NCT00643539","NCT00650273","NCT04395768","NCT04361422","NCT02176057","NCT05465304","NCT04366089","NCT04452617","NCT05132829","NCT03474276","NCT03948620","NCT05819918","NCT01783743","NCT00084227","NCT03341273","NCT03925480","NCT01243008","NCT00002089","NCT04977960","NCT04699097","NCT03511118","NCT01825408","NCT00827502","NCT05151614","NCT04464291","NCT00082576","NCT04463420"],"aliases":["Zithromax","Z-Pack","Zmax"],"patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$20.8733/EA","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$7,619","description":"AZITHROMYCIN 1 GM PWD PACKET","retrievedDate":"2026-04-07"}],"allNames":"zithromax","offLabel":[],"timeline":[{"date":"1980-01-01","type":"neutral","_source":"Wikipedia","milestone":"Azithromycin discovered","regulator":"none"},{"date":"1981-01-01","type":"neutral","_source":"Wikipedia","milestone":"Patent granted","regulator":"none"},{"date":"2005-01-01","type":"neutral","_source":"Wikipedia","milestone":"Patent protection ended","regulator":"none"},{"date":"20051114","type":"positive","_source":"FDA ANDA065218","milestone":"FDA ORIG — PLIVA","regulator":"FDA","description":""},{"date":"20060706","type":"positive","_source":"FDA ANDA065246","milestone":"FDA ORIG — PLIVA","regulator":"FDA","description":""},{"date":"20090626","type":"positive","_source":"FDA ANDA065500","milestone":"FDA ORIG — HOSPIRA","regulator":"FDA","description":""},{"date":"20090928","type":"positive","_source":"FDA ANDA065246","milestone":"FDA SUPPL — PLIVA","regulator":"FDA","description":""},{"date":"20091109","type":"positive","_source":"FDA ANDA065501","milestone":"FDA ORIG — GLAND PHARMA LTD","regulator":"FDA","description":""},{"date":"20100728","type":"positive","_source":"FDA ANDA065223","milestone":"FDA SUPPL — PLIVA","regulator":"FDA","description":""},{"date":"20100824","type":"positive","_source":"FDA ANDA065501","milestone":"FDA SUPPL — GLAND PHARMA LTD","regulator":"FDA","description":""},{"date":"20120228","type":"positive","_source":"FDA ANDA065225","milestone":"FDA SUPPL — PLIVA","regulator":"FDA","description":""},{"date":"20121011","type":"positive","_source":"FDA ANDA065500","milestone":"FDA SUPPL — HOSPIRA","regulator":"FDA","description":""},{"date":"20130228","type":"positive","_source":"FDA ANDA065225","milestone":"FDA SUPPL — PLIVA","regulator":"FDA","description":""},{"date":"20140825","type":"positive","_source":"FDA ANDA065501","milestone":"FDA SUPPL — GLAND PHARMA LTD","regulator":"FDA","description":""},{"date":"20150319","type":"positive","_source":"FDA ANDA065500","milestone":"FDA SUPPL — HOSPIRA","regulator":"FDA","description":""},{"date":"20150319","type":"positive","_source":"FDA ANDA065501","milestone":"FDA SUPPL — GLAND PHARMA LTD","regulator":"FDA","description":""},{"date":"20150320","type":"positive","_source":"FDA ANDA065223","milestone":"FDA SUPPL — PLIVA","regulator":"FDA","description":""},{"date":"20161108","type":"positive","_source":"FDA ANDA065218","milestone":"FDA SUPPL — PLIVA","regulator":"FDA","description":""},{"date":"2017-01-01","type":"neutral","_source":"Wikipedia","milestone":"Second most prescribed antibiotic in the US","regulator":"none"},{"date":"20170105","type":"positive","_source":"FDA ANDA065501","milestone":"FDA SUPPL — GLAND PHARMA LTD","regulator":"FDA","description":""},{"date":"20170628","type":"positive","_source":"FDA ANDA065246","milestone":"FDA SUPPL — PLIVA","regulator":"FDA","description":""},{"date":"20180705","type":"positive","_source":"FDA ANDA207370","milestone":"FDA ORIG — AUROBINDO PHARMA LTD","regulator":"FDA","description":""},{"date":"20181009","type":"positive","_source":"FDA ANDA203412","milestone":"FDA ORIG — SLATE RUN PHARMA","regulator":"FDA","description":""},{"date":"20200108","type":"positive","_source":"FDA ANDA065218","milestone":"FDA SUPPL — PLIVA","regulator":"FDA","description":""},{"date":"20200123","type":"positive","_source":"FDA ANDA209201","milestone":"FDA SUPPL — AUROBINDO PHARMA LTD","regulator":"FDA","description":""},{"date":"20200127","type":"positive","_source":"FDA ANDA065500","milestone":"FDA SUPPL — HOSPIRA","regulator":"FDA","description":""},{"date":"20200127","type":"positive","_source":"FDA ANDA065501","milestone":"FDA SUPPL — GLAND PHARMA LTD","regulator":"FDA","description":""},{"date":"20200419","type":"positive","_source":"FDA ANDA203412","milestone":"FDA SUPPL — SLATE RUN PHARMA","regulator":"FDA","description":""},{"date":"20211122","type":"positive","_source":"FDA ANDA065218","milestone":"FDA SUPPL — PLIVA","regulator":"FDA","description":""},{"date":"2022-01-01","type":"neutral","_source":"Wikipedia","milestone":"Second most prescribed antibiotic in the US","regulator":"none"},{"date":"2022-01-01","type":"neutral","_source":"Wikipedia","milestone":"78th most commonly prescribed medication in the US","regulator":"none"},{"date":"20220112","type":"positive","_source":"FDA ANDA209201","milestone":"FDA SUPPL — AUROBINDO PHARMA LTD","regulator":"FDA","description":""},{"date":"20230206","type":"positive","_source":"FDA ANDA065218","milestone":"FDA SUPPL — PLIVA","regulator":"FDA","description":""},{"date":"20230313","type":"positive","_source":"FDA ANDA065501","milestone":"FDA SUPPL — GLAND PHARMA LTD","regulator":"FDA","description":""}],"aiSummary":"Azithromycin (Zithromax/Z-Pack) is one of the world\\","brandName":"Zithromax","companyId":"pfizer","ecosystem":[],"mechanism":{"target":"Canalicular multispecific organic anion transporter 1, Taste receptor type 2 member 4, Motilin receptor","novelty":"best-in-class","modality":"Small molecule","drugClass":"Macrolide antibiotic (azalide)","explanation":"Azithromycin is an azalide antibiotic (structurally related to macrolides) with a uniquely long tissue half-life of 68 hours, allowing short-course therapy (the famous \\","oneSentence":"Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life.","technicalDetail":"Azithromycin's mechanism of action involves the inhibition of bacterial protein synthesis through the binding of the 50S ribosomal subunit. This results in the disruption of protein synthesis, ultimately leading to bacterial cell death. The drug's broad-spectrum activity is due to its ability to target multiple bacterial species."},"commercial":{"revenueYear":2025,"annualRevenue":399,"revenueSource":"SEC 8-K Pfizer (2026-02-03)","revenueCurrency":"USD","revenueConfidence":"verified (SEC filing)","revenueExtractedAt":"2026-03-31T18:03:08.912876","revenueExtractedBy":"revenue-sec"},"references":[],"biosimilars":[],"companyName":"Pfizer Inc.","competitors":[{"name":"Doxycycline","company":"Doxycycline tablets and suspension","advantage":"Treats a range of bacterial infections in adults and children, including bronchitis, pneumonia, and skin infections."},{"name":"Amoxicillin","company":"Amoxicillin","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."},{"name":"Clindamycin","company":"Clindamycin","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."},{"name":"Cephalexin","company":"Cephalexin","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."},{"name":"Ciprofloxacin","company":"Ciprofloxacin","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."},{"name":"Metronidazole","company":"Metronidazole","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."},{"name":"Ceftriaxone","company":"Ceftriaxone","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."},{"name":"Levofloxacin","company":"Levofloxacin","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."},{"name":"Augmentin","company":"Amoxicillin / clavulanate","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."},{"name":"Erythromycin","company":"Erythromycin","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."},{"name":"Keflex","company":"Cephalexin","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."},{"name":"Amoxicillin / clavulanate","company":"Amoxicillin / clavulanate","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."},{"name":"Clarithromycin","company":"Clarithromycin","advantage":"Treats bacterial infections, including bronchitis, pneumonia, and skin infections."}],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"}],"genericName":"azithromycin","indications":{"approved":[{"name":"Acute bacterial bronchitis","diseaseId":"acute-bacterial-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute bacterial sinusitis","diseaseId":"acute-bacterial-sinusitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute exacerbation of chronic bronchitis","diseaseId":"acute-exacerbation-of-chronic-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute gonococcal cervicitis","diseaseId":"acute-gonococcal-cervicitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute gonococcal urethritis","diseaseId":"acute-gonococcal-urethritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial blepharitis","diseaseId":"bacterial-blepharitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial conjunctivitis","diseaseId":"bacterial-conjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial hordeolum","diseaseId":"bacterial-hordeolum","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial pneumonia","diseaseId":"bacterial-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chancroid","diseaseId":"chancroid","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chlamydia Cervicitis","diseaseId":"chlamydia-cervicitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chlamydial pelvic inflammatory disease","diseaseId":"chlamydial-pelvic-inflammatory-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chlamydial pneumonia","diseaseId":"chlamydial-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Dacryocystitis","diseaseId":"dacryocystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus Influenzae Acute Otitis Media","diseaseId":"haemophilus-influenzae-acute-otitis-media","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus influenzae pneumonia","diseaseId":"haemophilus-influenzae-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Staphylococcus aureus","diseaseId":"infection-due-to-staphylococcus-aureus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infective otitis media","diseaseId":"infective-otitis-media","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Legionella Pneumophila Pneumonia","diseaseId":"legionella-pneumophila-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Moraxella Catarrhalis Acute Otitis Media","diseaseId":"moraxella-catarrhalis-acute-otitis-media","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Moraxella Catarrhalis Pneumonia","diseaseId":"moraxella-catarrhalis-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pelvic Inflammatory Disease with Neisseria Gonorrhea","diseaseId":"pelvic-inflammatory-disease-with-neisseria-gonorrhea","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pelvic inflammatory disease due to Mycoplasma hominis","diseaseId":"pelvic-inflammatory-disease-due-to-mycoplasma-hominis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumococcal Acute Otitis Media","diseaseId":"pneumococcal-acute-otitis-media","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumococcal pneumonia","diseaseId":"pneumococcal-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumonia due to Mycoplasma pneumoniae","diseaseId":"pneumonia-due-to-mycoplasma-pneumoniae","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumonia due to Staphylococcus aureus","diseaseId":"pneumonia-due-to-staphylococcus-aureus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pulmonary Mycobacterium avium complex infection","diseaseId":"pulmonary-mycobacterium-avium-complex-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Streptococcus Agalactiae Infection","diseaseId":"skin-and-skin-structure-streptococcus-agalactiae-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcal tonsillitis","diseaseId":"streptococcal-tonsillitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcus pyogenes infection","diseaseId":"streptococcus-pyogenes-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Urethritis due to Chlamydia trachomatis","diseaseId":"urethritis-due-to-chlamydia-trachomatis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04235816","phase":"PHASE3","title":"Improving Care Through Azithromycin Research for Infants in Africa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Barcelona Institute for Global Health","startDate":"2021-03-15","conditions":"Child Mortality","enrollment":20560},{"nctId":"NCT06082037","phase":"PHASE3","title":"A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction","status":"RECRUITING","sponsor":"Sanofi","startDate":"2023-10-10","conditions":"Lung Transplant Rejection","enrollment":180},{"nctId":"NCT04185402","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-05-29","conditions":"Trachoma","enrollment":3931},{"nctId":"NCT03132116","phase":"PHASE3","title":"Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2017-05-31","conditions":"Cat-Scratch Disease","enrollment":75},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT04287049","phase":"PHASE2","title":"A Study of Standard Drugs for Mycobacterium Avium Complex","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2020-02-24","conditions":"Mycobacterium Avium Complex","enrollment":10},{"nctId":"NCT05994742","phase":"PHASE3","title":"An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-07-15","conditions":"Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions","enrollment":674},{"nctId":"NCT01233297","phase":"PHASE2","title":"Antibiotic Treatment of Recurrent Episodes of Asthma in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"Copenhagen Studies on Asthma in Childhood","startDate":"2010-11","conditions":"Childhood Asthma With Acute Exacerbation","enrollment":70},{"nctId":"NCT06289647","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma B","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2024-10","conditions":"Trachoma","enrollment":0},{"nctId":"NCT06488781","phase":"PHASE2","title":"Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2025-04-29","conditions":"Obesity in Pregnancy, Labor Complication","enrollment":787},{"nctId":"NCT04069312","phase":"PHASE4","title":"Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2020-02-11","conditions":"Chronic Obstructive Pulmonary Disease Severe, Chronic Bronchitis","enrollment":1032},{"nctId":"NCT07445282","phase":"PHASE4","title":"This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid Fever","status":"COMPLETED","sponsor":"Sheikh Zayed Medical College","startDate":"2025-05-14","conditions":"Extensively Drug-Resistant Typhoid Fever, Typhoid Fever, Salmonella Typhi Infection","enrollment":90},{"nctId":"NCT07443436","phase":"PHASE2","title":"Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-10-01","conditions":"Interstitial Lung Disease","enrollment":30},{"nctId":"NCT05949190","phase":"NA","title":"Improving Cognition and Gestational Duration With Targeted Nutrition","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2023-08-18","conditions":"Malnutrition in Pregnancy, Preterm Birth, Child Development","enrollment":1660},{"nctId":"NCT07436104","phase":"PHASE4","title":"Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat.","status":"COMPLETED","sponsor":"MAHAN Trust","startDate":"2004-01-01","conditions":"Hypertension (HTN), Diarrhea, Pneumonia","enrollment":72564},{"nctId":"NCT07433426","phase":"PHASE2","title":"The Impact of Shigellosis and Recommended Treatment in Children","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2026-03-15","conditions":"Diarrhea Infectious, Shigella, Growth & Development","enrollment":700},{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT05291468","phase":"NA","title":"the PHENOSAR Trial: Use of Antibiotics in Treatment of Sarcoidosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Antonius Hospital","startDate":"2023-02-15","conditions":"Sarcoidosis, Pulmonary, Sarcoidosis Skin","enrollment":40},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT05922761","phase":"PHASE2","title":"BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-05-31","conditions":"Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases","enrollment":45},{"nctId":"NCT03656926","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":169},{"nctId":"NCT05026749","phase":"PHASE3","title":"Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2022-02-27","conditions":"Respiratory Syncytial Virus Infections","enrollment":370},{"nctId":"NCT07394725","phase":"PHASE1","title":"Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management","status":"COMPLETED","sponsor":"District Headquarters Teaching Hospital Sahiwal","startDate":"2024-04-01","conditions":"Pre-term Premature Rupture of Membranes","enrollment":250},{"nctId":"NCT05796362","phase":"PHASE1","title":"A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2024-08-08","conditions":"Infectious Disease, Drug Effect, Clinical Infection","enrollment":18},{"nctId":"NCT04677569","phase":"PHASE3","title":"Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2021-04-01","conditions":"Mycobacterium Infections, Nontuberculous","enrollment":425},{"nctId":"NCT07384793","phase":"PHASE4","title":"Comparison of Efficacy of Azithromycin Alone vs Combination of Azithromycin and Probiotics in Management of Mild to Moderate Acne Vulgaris","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hayatabad Medical Complex","startDate":"2025-10-12","conditions":"Acne Vulgaris II or III Degree","enrollment":60},{"nctId":"NCT03909737","phase":"PHASE4","title":"Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2020-09-24","conditions":"Stillbirths and Infant Mortality","enrollment":99700},{"nctId":"NCT06605118","phase":"PHASE3","title":"Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial","status":"RECRUITING","sponsor":"The George Washington University Biostatistics Center","startDate":"2024-11-06","conditions":"Obstetrical Complications, Labor and Delivery Complication, Cesarean Delivery","enrollment":8000},{"nctId":"NCT03672630","phase":"PHASE2, PHASE3","title":"Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease","status":"COMPLETED","sponsor":"Kevin Winthrop","startDate":"2019-02-22","conditions":"Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection","enrollment":474},{"nctId":"NCT04481555","phase":"PHASE4","title":"Eosinophil-guided Reduction of Inhaled Corticosteroids","status":"COMPLETED","sponsor":"Chronic Obstructive Pulmonary Disease Trial Network, Denmark","startDate":"2021-06-28","conditions":"COPD, Inhaled Corticosteroid, Azithromycin","enrollment":444},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT04294641","phase":"PHASE2","title":"Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2021-05-10","conditions":"Chronic GVHD","enrollment":10},{"nctId":"NCT06077916","phase":"NA","title":"Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy","status":"COMPLETED","sponsor":"Clinical Hospital Colentina","startDate":"2023-10-01","conditions":"Upper Gastrointestinal Bleeding","enrollment":224},{"nctId":"NCT04349826","phase":"PHASE4","title":"The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)","status":"COMPLETED","sponsor":"Oxford University Clinical Research Unit, Vietnam","startDate":"2021-05-23","conditions":"Typhoid Fever","enrollment":2150},{"nctId":"NCT05842681","phase":"NA","title":"Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Assiut University","startDate":"2023-06-01","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":30},{"nctId":"NCT03083197","phase":"PHASE4","title":"Scrub Typhus Antibiotic Resistance Trial","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2017-10-15","conditions":"Scrub Typhus","enrollment":177},{"nctId":"NCT07320612","phase":"PHASE1","title":"Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome","status":"COMPLETED","sponsor":"University of Child Health Sciences and Children's Hospital, Lahore","startDate":"2025-03-08","conditions":"Nephrotic Syndrome","enrollment":160},{"nctId":"NCT07314281","phase":"PHASE4","title":"Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever","status":"RECRUITING","sponsor":"Indus Hospital and Health Network","startDate":"2025-04-22","conditions":"Enteric Fever","enrollment":40},{"nctId":"NCT07296302","phase":"NA","title":"Antibiotic Prophylaxis Versus Placebo in Alveolar Bone Grafting: A Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Agnaldo Rocha de Souza Junior","startDate":"2026-02","conditions":"Alveolar Ridge Augmentation, Bone Grafting, Antibiotic Prophylaxis","enrollment":150},{"nctId":"NCT07306234","phase":"PHASE4","title":"Doxycycline vs. Macrolide for MRMP (DOMINO)","status":"NOT_YET_RECRUITING","sponsor":"Young June Choe","startDate":"2026-03-01","conditions":"Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia","enrollment":208},{"nctId":"NCT07183462","phase":"PHASE4","title":"Azithromycin and Ampicillin for Late PPROM","status":"RECRUITING","sponsor":"Sheba Medical Center","startDate":"2025-09-10","conditions":"Pregnancy Complications, Infectious, Premature Birth, Neonatal Diseases and Abnormalities","enrollment":311},{"nctId":"NCT06223828","phase":"PHASE2, PHASE3","title":"Azithromycin for Critical Asthma - Pediatrics","status":"RECRUITING","sponsor":"Johns Hopkins All Children's Hospital","startDate":"2024-04-02","conditions":"Pediatric Asthma, Critical Illness","enrollment":100},{"nctId":"NCT02754583","phase":"PHASE3","title":"Sanitation, Water, and Instruction in Face-washing for Trachoma I/II","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-12-05","conditions":"Trachoma","enrollment":47605},{"nctId":"NCT05654922","phase":"PHASE3","title":"Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant","status":"RECRUITING","sponsor":"Renovion, Inc.","startDate":"2023-04-10","conditions":"Pre-Bronchiolitis Obliterans Syndrome","enrollment":100},{"nctId":"NCT04344379","phase":"PHASE3","title":"Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-17","conditions":"SARS-CoV-2 Infection","enrollment":122},{"nctId":"NCT06468462","phase":"PHASE4","title":"Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-10-29","conditions":"Gonorrhea Male, Chlamydia (Male), Syphilis Male","enrollment":2900},{"nctId":"NCT03236987","phase":"PHASE3","title":"CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2018-02-05","conditions":"Lung Infection, MAC Lung Disease","enrollment":424},{"nctId":"NCT06418711","phase":"PHASE3","title":"ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension","status":"TERMINATED","sponsor":"Mannkind Corporation","startDate":"2024-09-11","conditions":"MAC Lung Disease, Treatment Refractory MAC Lung Disease, Mycobacterium Infections, Nontuberculous","enrollment":132},{"nctId":"NCT06618534","phase":"PHASE2","title":"Azithromycin for Meningococcal Carriage","status":"RECRUITING","sponsor":"Emory University","startDate":"2024-11-12","conditions":"Meningococcal Infections","enrollment":1120},{"nctId":"NCT03250975","phase":"PHASE1, PHASE2","title":"Incidence of Acute Laryngeal Injury Following Endotracheal Intubation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2017-08-19","conditions":"Intubation Complication","enrollment":64},{"nctId":"NCT07052942","phase":"PHASE4","title":"Individualizing Treatment for Asthma in Primary Care (Full Study)","status":"RECRUITING","sponsor":"DARTNet Institute","startDate":"2025-08-01","conditions":"Asthma, Asthma Attack, Asthma Exacerbations","enrollment":3200},{"nctId":"NCT03657342","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":62},{"nctId":"NCT03335072","phase":"PHASE4","title":"Kebele Elimination of Trachoma for Ocular Health","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-02-07","conditions":"Trachoma","enrollment":320000},{"nctId":"NCT06010719","phase":"PHASE4","title":"Azithromycin as Adjunctive Treatment for Uncomplicated Severe Acute Malnutrition","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-10-23","conditions":"Malnutrition, Child, Severe Acute Malnutrition","enrollment":3000},{"nctId":"NCT07213765","phase":"PHASE4","title":"Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease","status":"RECRUITING","sponsor":"Bin Cao","startDate":"2025-07-24","conditions":"Mycobacterium Avium Complex Pulmonary Disease","enrollment":188},{"nctId":"NCT07164131","phase":"PHASE4","title":"Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-09-15","conditions":"Community-acquired Pneumonia","enrollment":1120},{"nctId":"NCT03959527","phase":"PHASE3","title":"Zoliflodacin in Uncomplicated Gonorrhoea","status":"COMPLETED","sponsor":"Global Antibiotics Research and Development Partnership","startDate":"2019-11-06","conditions":"Gonorrhea","enrollment":1011},{"nctId":"NCT05086432","phase":"NA","title":"Sputum Cytometry Guided Management for the Elimination of Chronic Cough in Patients With ILD","status":"RECRUITING","sponsor":"McMaster University","startDate":"2025-05-22","conditions":"ILD","enrollment":120},{"nctId":"NCT07084402","phase":"PHASE4","title":"Short-term Bactericidal Effect of Contezolid in MAC-PD","status":"RECRUITING","sponsor":"Bin Cao","startDate":"2025-07-24","conditions":"Mycobacterium Avium Complex Pulmonary Disease","enrollment":188},{"nctId":"NCT06273891","phase":"PHASE3","title":"Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2024-03-08","conditions":"Premature Rupture of Membrane","enrollment":140},{"nctId":"NCT06543290","phase":"PHASE1","title":"Azithromycin Before Induction","status":"RECRUITING","sponsor":"Arrowhead Regional Medical Center","startDate":"2023-08-07","conditions":"Infections","enrollment":400},{"nctId":"NCT02707042","phase":"PHASE1","title":"Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-03-22","conditions":"Normal Physiology, Healthy","enrollment":108},{"nctId":"NCT03925480","phase":"PHASE3","title":"Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2019-07-01","conditions":"Bacterial Infections","enrollment":2110},{"nctId":"NCT05580666","phase":"PHASE3","title":"Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2023-05-08","conditions":"HIV Disease Progression","enrollment":8000},{"nctId":"NCT05763693","phase":"PHASE4","title":"Vitality in Infants Via Azithromycin for Neonates Trial","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-04","conditions":"Neonatal Death, Infectious Disease, Nutritional Deficiency","enrollment":4000},{"nctId":"NCT05157685","phase":"PHASE3","title":"Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2022-11-21","conditions":"Sinusitis, Chronic, Sinus Infection Chronic","enrollment":230},{"nctId":"NCT07148622","phase":"NA","title":"Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2024-10-01","conditions":"Preterm Premature Rupture of Membranes (PPROM), Prophylaxis, Perinatal Outcomes","enrollment":40},{"nctId":"NCT03273296","phase":"PHASE4","title":"Effect of Antibiotics on Gut Microbiome and Plasma Metabolome","status":"COMPLETED","sponsor":"Finnish Institute for Health and Welfare","startDate":"2017-10-15","conditions":"Microbial Colonization","enrollment":39},{"nctId":"NCT05121974","phase":"PHASE2","title":"Tebipenem Trial in Children With Shigellosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2022-08-18","conditions":"Shigellosis","enrollment":132},{"nctId":"NCT04921943","phase":"PHASE4","title":"Hypertonic Saline for MAC","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2021-05-18","conditions":"Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection","enrollment":50},{"nctId":"NCT04310930","phase":"PHASE2, PHASE3","title":"Finding the Optimal Regimen for Mycobacterium Abscessus Treatment","status":"RECRUITING","sponsor":"The University of Queensland","startDate":"2020-03-02","conditions":"Pulmonary Disease Due to Mycobacteria (Diagnosis)","enrollment":300},{"nctId":"NCT03953118","phase":"PHASE4","title":"Azithromycin for Meibomian Gland Disease","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2019-09-01","conditions":"Dry Eye, Neuropathic Eye Pain, Ocular Microbiome","enrollment":2},{"nctId":"NCT04480242","phase":"","title":"Asthma Research in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Parc de Salut Mar","startDate":"2017-07-26","conditions":"Persistent Asthma, Asthma in Children, Asthma Exacerbation","enrollment":525},{"nctId":"NCT05961189","phase":"EARLY_PHASE1","title":"Influence of Short-Term Antibiotic Therapy on Exercise","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2023-09-01","conditions":"Gastrointestinal Microbiome, Exercise","enrollment":40},{"nctId":"NCT06584474","phase":"PHASE4","title":"THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-10-02","conditions":"Bronchopulmonary Dysplasia, Premature, Ventilation, Mechanical","enrollment":100},{"nctId":"NCT03523156","phase":"PHASE4","title":"Trachoma Elimination Study by Focused Antibiotic (TESFA)","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2025-06","conditions":"Trachoma","enrollment":0},{"nctId":"NCT07064278","phase":"NA","title":"Combined Diagnostic Approach for Refractory Mycoplasma Pneumonia in Children","status":"COMPLETED","sponsor":"Children's Hospital of Hebei Province","startDate":"2022-12-01","conditions":"Refractory Mycoplasma Pneumoniae Pneumonia","enrollment":260},{"nctId":"NCT04326478","phase":"PHASE2","title":"Single Dose Azithromycin to Prevent Cholera in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-10-31","conditions":"Cholera","enrollment":920},{"nctId":"NCT04186247","phase":"PHASE2","title":"Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2021-08-13","conditions":"Crohn Disease, Pediatric Crohns Disease","enrollment":13},{"nctId":"NCT03479736","phase":"","title":"A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-20","conditions":"Retinal Detachment, Achilles Tendon, Aneurysm, Dissecting","enrollment":117911},{"nctId":"NCT06358872","phase":"PHASE4","title":"Azithromycin for Child Survival in Niger II","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-04-29","conditions":"Mortality, Antimicrobial Resistance","enrollment":3300000},{"nctId":"NCT06461429","phase":"NA","title":"PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol]","status":"NOT_YET_RECRUITING","sponsor":"University of Melbourne","startDate":"2025-11-01","conditions":"Preterm Birth","enrollment":100000},{"nctId":"NCT05677282","phase":"PHASE4","title":"Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct","status":"RECRUITING","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2022-10-28","conditions":"Diarrhoea;Acute, Diarrhea Travelers","enrollment":150},{"nctId":"NCT03162497","phase":"PHASE4","title":"Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2018-01-08","conditions":"Dry Eye Syndromes, Meibomian Gland Dysfunction","enrollment":23},{"nctId":"NCT05469555","phase":"","title":"Azithromycin and Oesophageal Function in Respiratory Disease","status":"COMPLETED","sponsor":"Hull University Teaching Hospitals NHS Trust","startDate":"2023-06-29","conditions":"Cough, Asthma, Copd","enrollment":30},{"nctId":"NCT04424511","phase":"PHASE3","title":"Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Mali","status":"COMPLETED","sponsor":"Tampere University","startDate":"2020-10-15","conditions":"Mortality","enrollment":149201},{"nctId":"NCT04224987","phase":"PHASE4","title":"Azithromycin for Child Survival in Niger: Mortality and Resistance Trial","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2020-11-24","conditions":"Mortality, Resistance Bacterial, Child, Only","enrollment":864493},{"nctId":"NCT06958146","phase":"PHASE4","title":"Azithromycin for Preventing Maternal and Neonatal Infections During Labor.","status":"NOT_YET_RECRUITING","sponsor":"Armed Forces Hospital, Pakistan","startDate":"2025-05-01","conditions":"Maternal and Neonatal Sepsis, Intrapartum Antibiotics","enrollment":400},{"nctId":"NCT04774991","phase":"PHASE4","title":"Azithromycin for Child Survival in Niger: Delivery Trial","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-06-28","conditions":"Mortality, Child Health, Implementation","enrollment":10925},{"nctId":"NCT05345457","phase":"PHASE4","title":"Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age","status":"RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2023-01-13","conditions":"Pregnancy Preterm, Pregnancy Prom, PROM, Preterm (Pregnancy)","enrollment":88},{"nctId":"NCT06272370","phase":"PHASE4","title":"Individualizing Treatment for Asthma in Primary Care","status":"COMPLETED","sponsor":"DARTNet Institute","startDate":"2024-02-01","conditions":"Asthma, Bronchial Diseases, Respiratory Tract Infections","enrollment":103},{"nctId":"NCT05028153","phase":"PHASE2","title":"Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms","status":"RECRUITING","sponsor":"Copenhagen Studies on Asthma in Childhood","startDate":"2022-11-14","conditions":"Childhood Asthma With Acute Exacerbation","enrollment":320},{"nctId":"NCT06921525","phase":"PHASE1, PHASE2","title":"Comparing Efficacy of Tea Tree Oil Versus Topical Azithromycin in Treating Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"Ehab Mohamed Elsayed Mohamed Saad","startDate":"2025-04-01","conditions":"Dry Eye","enrollment":44},{"nctId":"NCT06917157","phase":"PHASE4","title":"Latency Antibiotics for Previable Rupture Of Membranes Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-05-01","conditions":"Preterm Prelabor Rupture of Membranes (PPROM)","enrollment":60},{"nctId":"NCT05847322","phase":"NA","title":"Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks","status":"RECRUITING","sponsor":"University of Southampton","startDate":"2022-12-06","conditions":"Pertussis/Whooping Cough","enrollment":72},{"nctId":"NCT05599347","phase":"PHASE2","title":"Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease","status":"RECRUITING","sponsor":"Rambam Health Care Campus","startDate":"2023-04-24","conditions":"Crohn's Disease Relapse, Biological Substance; Adverse Effect","enrollment":180},{"nctId":"NCT06906757","phase":"NA","title":"Preterm Rupture of Membranes Optimising Antibiotics Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Melbourne","startDate":"2025-09","conditions":"PPROM, Preterm","enrollment":3900},{"nctId":"NCT06325293","phase":"NA","title":"A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study","status":"RECRUITING","sponsor":"Christoph Berger","startDate":"2025-01-28","conditions":"Community Acquired Pneumonia in Children, Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia","enrollment":376},{"nctId":"NCT05288023","phase":"PHASE4","title":"Azithromycin for Child Survival in Niger: Programmatic Trial (AVENIR)","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2022-12-01","conditions":"Resistance Bacterial, Morality, Child Health","enrollment":169707},{"nctId":"NCT00131235","phase":"PHASE3","title":"Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tampere University","startDate":"2003-12","conditions":"Malaria, Sexually Transmitted Diseases, Preterm Birth","enrollment":1320}],"whoEssential":true,"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"Oral, Intravenous, Ophthalmic","frequency":"Once daily (typically 3-5 day course)","formulation":"Tablet, Oral suspension, IV injection, Eye drops"},"crossReferences":{"unii":"5FD1131I7S","rxcui":"18631","splId":"6efa1622-de6a-4eee-b5bb-6a8149bbe1c1","chemblId":"CHEMBL4299381","pubchemSID":"9056"},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[{"notes":"Patented azithromycin in 1981","period":"1980-2005","_source":"Wikipedia","companyName":"Pliva","relationship":"Originator"}],"therapeuticAreas":["Infectious Disease"],"_revenueScrapedAt":"2026-04-08 13:58:28.162018+00","biosimilarFilings":[],"firstApprovalDate":"1991-11-01","companionDiagnostics":[],"firstApprovalCountry":"United States","genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":3,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2018-10-09T00:00:00.000Z","mah":"SLATE RUN PHARMA","brand_name_local":null,"application_number":"ANDA203412"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2020-04-11T00:00:00.000Z","mah":"SUN PHARM INDS LTD","brand_name_local":null,"application_number":"ANDA090923"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2021-11-22T00:00:00.000Z","mah":"PFIZER","brand_name_local":null,"application_number":"NDA050784"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2022-07-12T00:00:00.000Z","mah":"STRIDES PHARMA","brand_name_local":null,"application_number":"ANDA215773"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2024-07-08T00:00:00.000Z","mah":"STRIDES PHARMA","brand_name_local":null,"application_number":"ANDA215772"},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"Un","currency":"USD","price_amount":"7619.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null},{"country_code":"UN","currency":"USD","price_amount":"7619.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":7,"withResults":3},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}